Impact of genetic background and ablation of insulin receptor substrate (IRS)-3 on IRS-2 knock-out mice

被引:22
作者
Terauchi, Y
Matsui, J
Suzuki, R
Kubota, N
Komeda, K
Aizawa, S
Eto, K
Kimura, S
Nagai, R
Tobe, K
Lienhard, GE
Kadowaki, T
机构
[1] Univ Tokyo, Grad Sch Med, Dept Internal Med, Tokyo 1138655, Japan
[2] JST, CREST, Kawaguchi 3320012, Japan
[3] Tokyo Med Univ, Anim Res Ctr, Div Lab Anim Sci, Tokyo 1608402, Japan
[4] RIKEN, Ctr Dev Biol, Lab Vertebrate Body Plan, Kobe, Hyogo 6500047, Japan
[5] Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA
关键词
D O I
10.1074/jbc.M211045200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although we and others have generated IRS-2 knockout (IRS-2(-/-)) mice, significant differences were seen between the two lines of IRS-2(-/-) mice in the severity of diabetes and alterations of beta-cell mass. It has been reported that although IRS-1 and IRS-3 knock-out mice showed normal blood glucose levels, IRS-1/IRS-3 double knock-out mice exhibited marked hyperglycemia. Thus, IRS-1 and IRS-3 compensate each other's functions in maintaining glucose homeostasis. To assess the effect of genetic background and also ablation of IRS-3 on IRS2-1-, we generated IRS-2/IRS-3 double knock-out (IRS2-1-IRS-3-1-) mice by crossing IRS-3(-/-) mice (129/Sv and C57B1/6 background) with our IRS-2(-/-) mice (CBA and C57B1/6 background). Intercrosses of IRS-2(+/-)IRS-3(+/-)mice yielded nine genotypes, and all of them including IRS-2(-/-)IRS-3(-/-) mice were apparently healthy and showed normal growth. However, at 10-20 weeks of age, 20-30% mice carrying a null mutation for the IRS-2 gene, irrespective of the IRS-3 genotype, developed diabetes. When mice with diabetes were excluded from the analysis of glucose and insulin tolerance test, IRS-2(-/-)IRS3(-/-) showed a degree of glucose intolerance and insulin resistance similar to those of IRS-2(-/-) mice. Both IRS2-1- and IRS-2(-/-)IRS-3(-/-) mice had moderately reduced beta-cell mass despite having insulin resistance. Insulin-positive beta-cells were decreased to nearly zero in IRS2(-/-) mice with diabetes. Although Pdx1 and glucose transporter 2 expressions were essentially unaltered in islets from IRS-2(-/-) mice without diabetes, they were dramatically decreased in IRS-2(-/-) mice with diabetes. Taken together, these observations indicate that IRS-3 does not play a role compensating for the loss of IRS-2 in maintaining glucose homeostasis and that the severity of diabetes in IRS-2(-/-) mice depends upon genetic background, suggesting the existence of modifier gene(s) for diabetes in mice of the 129/Sv genetic strain.
引用
收藏
页码:14284 / 14290
页数:7
相关论文
共 29 条
  • [1] ALTERNATIVE PATHWAY OF INSULIN SIGNALING IN MICE WITH TARGETED DISRUPTION OF THE IRS-1 GENE
    ARAKI, E
    LIPES, MA
    PATTI, ME
    BRUNING, JC
    HAAG, B
    JOHNSON, RS
    KAHN, CR
    [J]. NATURE, 1994, 372 (6502) : 186 - 190
  • [2] Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles
    Bruning, JC
    Winnay, J
    BonnerWeir, S
    Taylor, SI
    Accili, D
    Kahn, CR
    [J]. CELL, 1997, 88 (04) : 561 - 572
  • [3] Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion
    Eto, K
    Tsubamoto, Y
    Terauchi, Y
    Sugiyama, T
    Kishimoto, T
    Takahashi, N
    Yamauchi, N
    Kubota, N
    Murayama, S
    Aizawa, S
    Akanuma, Y
    Aizawa, S
    Kasai, H
    Yazaki, Y
    Kadowaki, T
    [J]. SCIENCE, 1999, 283 (5404) : 981 - 985
  • [4] NADH shuttle system regulates KATP channel-dependent pathway and steps distal to cytosolic Ca2+ concentration elevation in glucose-induced insulin secretion.
    Eto, K
    Suga, S
    Wakui, M
    Tsubamoto, Y
    Terauchi, Y
    Taka, J
    Aizawa, S
    Noda, M
    Kimura, S
    Kasai, H
    Kadowaki, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (36) : 25386 - 25392
  • [5] ISHII C, 1996, DIABETES RES, V31, P1
  • [6] KADOWAKI T, 1987, J BIOL CHEM, V262, P7342
  • [7] Beneficial effects of antioxidants in diabetes -: Possible protection of pancreatic β-cells against glucose toxicity
    Kaneto, H
    Kajimoto, Y
    Miyagawa, J
    Matsuoka, T
    Fujitani, Y
    Umayahara, Y
    Hanafusa, T
    Matsuzawa, Y
    Yamasaki, K
    Hori, M
    [J]. DIABETES, 1999, 48 (12) : 2398 - 2406
  • [8] Genetic modifiers of the insulin resistance phenotype in mice
    Kido, Y
    Philippe, N
    Schäffer, AA
    Accili, D
    [J]. DIABETES, 2000, 49 (04) : 589 - 596
  • [9] Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory β-cell hyperplasia
    Kubota, N
    Tobe, K
    Terauchi, Y
    Eto, K
    Yamauchi, T
    Suzuki, R
    Tsubamoto, Y
    Komeda, K
    Nakano, I
    Miki, H
    Satoh, S
    Sekihara, H
    Sciacchitano, S
    Lesniak, M
    Aizawa, S
    Nagai, R
    Kimura, S
    Akanuma, Y
    Taylor, SI
    Kadowaki, T
    [J]. DIABETES, 2000, 49 (11) : 1880 - 1889
  • [10] PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance
    Kubota, N
    Terauchi, Y
    Miki, H
    Tamemoto, H
    Yamauchi, T
    Komeda, K
    Satoh, S
    Nakano, R
    Ishii, C
    Sugiyama, T
    Eto, K
    Tsubamoto, Y
    Okuno, A
    Murakami, K
    Sekihara, H
    Hasegawa, G
    Naito, M
    Toyoshima, Y
    Tanaka, S
    Shiota, K
    Kitamura, T
    Fujita, T
    Ezaki, O
    Aizawa, S
    Nagai, R
    Tobe, K
    Kimura, S
    Kadowaki, T
    [J]. MOLECULAR CELL, 1999, 4 (04) : 597 - 609